Search results
Results From The WOW.Com Content Network
Emerging Infectious Diseases is a monthly open-access peer-reviewed medical journal published by the Centers for Disease Control and Prevention. [1] The journal is in the public domain [2] and covers global instances of new and reemerging infectious diseases, putting greater emphasis on disease emergence, prevention, control, and elimination.
Scientific Advisory Group for Origins of Novel Pathogens (or SAGO) [1] [2] [3] is a permanent advisory body of the World Health Organization, formed in July 2021, with a broad objective to examine emerging infectious diseases, including COVID-19.
ISARIC was founded in 2011. [4] In 2012, ISARIC joined with the World Health Organization to launch the Clinical Characterisation Protocol (CCP) program. [5] Its founders cited the 2002–2004 SARS outbreak, 2009 swine flu outbreak and later 2012 MERS outbreak as inciting incidents for the creation of an open source platform for sharing clinical research on emerging infectious diseases.
An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently (in the past 20 years), and could increase in the near future. [ 2 ] [ 3 ] The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or ...
The International Conference on Emerging Infectious Diseases was first convened in 1998; ICEID 2006 marks its fifth occurrence. The conference brings together public health professional to encourage the exchange of scientific and public health information on global emerging infectious disease issues.
ProMED embodied this concept in the sphere of infectious disease reporting since its inception. It is estimated that 70% of emerging human diseases originate in other animal species – termed zoonotic diseases. As diseases in both animal and agriculture species have health implications for humans, ProMED includes posts on emerging animal ...
The lab is part of a national network of secure facilities that study infectious diseases, whether naturally occurring or introduced through bioterrorism. NEIDL is one of only 13 operational or planned biosafety level 4 (BSL-4) laboratories in the United States. NEIDL's current director is Nancy Sullivan, ScD.
Shi is the director of the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology (WIV), located in Jiangxia District, Wuhan. [8] On her resume, Shi mentioned receiving grant funding from U.S. government sources totaling more than US$1.2 million, including $665,000 from the National Institutes of Health from 2014 to 2019, as well as US$559,500 over the same period from USAID.